Background
Periodontitis is characterized by periodontal tissue destruction and subsequent tooth loss, significantly impacting quality of life. The potential of HAX1, a gene implicated in periodontitis pathogenesis, to modulate the differentiation of periodontal ligament stem cells (PDLSCs) and its therapeutic potential remains unexplored.
Methods
PDLSCs were randomly divided into seven experimental groups, undergoing either HAX1 overexpression or knockdown treatments, followed by lipogenic or osteogenic induction. Lipogenic differentiation was assessed via Oil Red O staining, while osteogenic differentiation was evaluated by ALP staining. Mineralization capacity was determined by Alizarin red staining, and proliferative activity was measured with CCK-8 assays. RT-qPCR and Western blot analyses were employed to quantify mRNA and protein expression of genes associated with the RAF/MEK/ERK signaling pathway and to validate the efficacy of HAX1 manipulation.
Results
Validation of mRNA and protein expression confirmed successful establishment and screening of HAX1-overexpressing and -knockdown cell lines. Subsequent investigations revealed that HAX1 overexpression enhanced osteogenic differentiation and mineralization of PDLSCs while suppressing proliferation and lipogenic differentiation. Conversely, HAX1 knockdown yielded opposing effects. Analysis of the RAF/MEK/ERK signaling pathway demonstrated that HAX1 overexpression significantly promoted MEK/ERK phosphorylation and pathway activation, without affecting the RAF family.
Conclusion
HAX1 overexpression activates the ERK/MEK-mediated MAPK signaling pathway, which promotes osteogenic differentiation and inhibits lipid differentiation in PDLSCs, with positive therapeutic implications in periodontitis.
扫码关注我们
求助内容:
应助结果提醒方式:
